Verbal memory is impaired in neurological and psychiatric conditions and provides one of the main targets of intervention. Specifically, this cognitive domain has been shown to provide a major determinant of outcome in schizophrenia and mood disorders. Therefore, verbal memory disturbances should be focused in the development of novel pharmacological and psychosocial therapeutics. Effective integration between preclinical and clinical studies should provide a key to the pursuit of drugs enhancing verbal memory.
CITATION STYLE
Sumiyoshi, T. (2015). Verbal memory. Handbook of Experimental Pharmacology, 228, 237–247. https://doi.org/10.1007/978-3-319-16522-6_8
Mendeley helps you to discover research relevant for your work.